financetom
Business
financetom
/
Business
/
Supernus Pharmaceuticals Insider Sold Shares Worth $436,573, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Supernus Pharmaceuticals Insider Sold Shares Worth $436,573, According to a Recent SEC Filing
Mar 21, 2024 2:25 PM

05:06 PM EDT, 03/21/2024 (MT Newswires) -- Padmanabh P. Bhatt, Senior Vice President of Intellectual Property and Chief Scientific Officer, on March 19, 2024, sold 12,364 shares in Supernus Pharmaceuticals ( SUPN ) for $436,573. Following the Form 4 filing with the SEC, Bhatt has control over a total of 8,570 shares of the company, with 8,570 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000110465924037376/xslF345X03/tm249377-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Retail investors buy Novo dip after disappointing weight-loss drug data
Retail investors buy Novo dip after disappointing weight-loss drug data
Dec 24, 2024
By Bhanvi Satija (Reuters) - U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research. Daily net flows climbed to $15.6 million from $0.49 million a day earlier, after eagerly anticipated data showed Novo's experimental drug, CagriSema, helped patients cut 22.7%...
Mexico's oil and gas output drops to lowest level all year in November
Mexico's oil and gas output drops to lowest level all year in November
Dec 24, 2024
MEXICO CITY, Dec 24 (Reuters) - Mexico's production of liquid hydrocarbon and natural gas in November fell to the lowest levels recorded all year and was well below last year's averages, official numbers published by the regulator showed. November was also the second month the country missed the 1.8 million barrel-per-day production target for crude oil and condensate, which President...
Retail investors buy Novo dip after disappointing weight-loss drug data
Retail investors buy Novo dip after disappointing weight-loss drug data
Dec 24, 2024
By Bhanvi Satija Dec 24 (Reuters) - U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research. Daily net flows climbed to $15.6 million from $0.49 million a day earlier, after eagerly anticipated data showed Novo's experimental drug, CagriSema, helped patients...
BRIEF-Waterous Energy Fund Acquires Shares Of Greenfire Resources Ltd
BRIEF-Waterous Energy Fund Acquires Shares Of Greenfire Resources Ltd
Dec 24, 2024
Dec 24 (Reuters) - Greenfire Resources Ltd ( GFR ): * WATEROUS ENERGY FUND ACQUIRES SHARES OF GREENFIRE RESOURCES LTD. * WATEROUS ENERGY FUND MANAGEMENT: PURCHASED AGGREGATE OF 9.3 MILLION COMMON SHARES & 2.7 MILLION COMMON SHARE PURCHASE WARRANTS OF GREENFIRE RESOURCES * WATEROUS ENERGY FUND MANAGEMENT: PROPOSED DEAL FOR AGGREGATE PURCHASE PRICE OF US$81.9 MILLION Source text: Further company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved